NSE filing, NSE: GPTHEALTH. Summary written from the filing by ALFA Finder's alert engine.
GPT Healthcare Ltd: key numbers
- Share price
- ₹143.94
- Market cap
- ₹1,181 Cr
- Revenue (annual)
- ₹472.6 Cr
- Net profit (annual)
- ₹42.22 Cr
- P/E (TTM)
- 25.0×Sector 54.5×
- Promoter holding
- 65.57%+0.00% QoQ
- FII holding
- 3.01%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from GPT Healthcare Ltd
All →GPT Healthcare Results Update
GPT Healthcare filed a press release on unaudited Q2 and H1 FY27 results, reporting H1 total income of Rs 266.8 Cr and PAT of Rs 28.1 Cr. The release carries a P&L highlights table without the full SEBI results statement.
GPT Healthcare Investor Presentation: Key Takeaways
Q2 FY27 revenue ₹135.6 Cr (+14.0%), EBITDA ₹29.8 Cr (21.5% margin), PAT ₹15.4 Cr (+45.2%). H1 PAT ₹28.1 Cr (+53.9%). Eastern India expansion; 1,000-bed target.
GPT Healthcare Q2 FY27 Results: Net Profit ₹15.4 Cr, Up 45.3% YoY
GPT Healthcare approved unaudited Q2 and half-year results, with H1 revenue of Rs 26,182.60 lakh. A 10% interim dividend was declared with a November 12 record date.
- Key figure
- Net profit ₹15.4 Cr · +45.3% YoY
GPT Healthcare Board Meeting Date
GPT Healthcare will hold a board meeting on 05 Nov 2026 to consider Q2 and half-year unaudited results and a possible interim dividend for FY 2026-27. Trading window stays closed until 07 Nov 2026.
GPT Healthcare Other Announcement
The company submitted its quarterly shareholding pattern for the period ended September 30, 2026, in compliance with SEBI Regulation 31(1)(b).
GPT Healthcare Annual General Meeting
GPT Healthcare Limited held its 37th Annual General Meeting on August 6, 2026. Shareholders transacted ordinary and special business items as stated in the notice.
Other dividend announcements
All →Astral Dividend
Astral Limited's board approved Q2 and H1 FY2026-27 unaudited results and an interim dividend of Rs. 1.50 per share. Record date is November 13, 2026, and two senior management personnel were designated.
Insecticides (India) Dividend
Insecticides (India) declared an interim dividend of Rs.5 per equity share on 5 November 2026 for 2026-2027. Record date is 12 November 2026 and payment is proposed by 17 November 2026.
- Execution
- 2026-2027
Emami Dividend
Emami Limited declared an interim dividend of Rs 5 per equity share for FY 2026-27 at its board meeting on 5 November 2026. The record date for the dividend is 13 November 2026.
IRB Infrastructure Developers Dividend
IRB Infrastructure declared an interim dividend of Rs 0.05 per share on 5 November 2026. Record date is 12 November, with payment by 4 December 2026.
NLC India Dividend
NLC India's board declared an interim dividend of Rs 1.50 per equity share for FY 2026-27 on 4 Nov 2026. Record date is 12 Nov 2026 and payment by 3 Dec 2026.
Esab India Dividend
ESAB India declared an interim dividend of Rs. 20 per share for FY 2026-27. Record date is November 10, 2026, with payment by December 1, 2026.